Concepedia

Philippe Szapary

PS

Statistics

Publications

42

Citations

9.3K

H-Index

36

Active since

2003

Affiliations

Janssen (United States)(Current)

University of Pennsylvania

Icahn School of Medicine at Mount Sinai

University of California San Diego

Dermatologikum Hamburg

Philippe Szapary is an author at Janssen (United States) specializing in medicine, psoriatic disease, and rheumatology.

Publications per year

2003–2019

42

Publications

42

A Randomized Trial of a Low-Carbohydrate Diet for Obesity

Gary D. Foster, Holly R. Wyatt, James O. Hill et al. · New England Journal of Medicine · 2003 · 1.8K citations

Agriculture, Nutrition, Nutritional Sciences +14

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

Kim Papp, Richard G. Langley, Mark Lebwohl et al. · The Lancet · 2008 · 1.4K citations

Medicine, Dermatology, Immunology +15

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

Bruce E. Sands, William J. Sandborn, Remo Panaccione et al. · New England Journal of Medicine · 2019 · 1.2K citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Guselkumab (an IL-23–specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis

Howard Sofen, Stacy Smith, Robert Matheson et al. · Journal of Allergy and Clinical Immunology · 2014 · 302 citations · Full text

Life Sciences, Dermatology, Immunology +17

A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis

Kenneth B. Gordon, Kristina Callis Duffin, Robert Bissonnette et al. · New England Journal of Medicine · 2015 · 298 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15

1–5 of 42